The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127072681 12707268 1 I 20160824 20160901 20160901 EXP US-DRREDDYS-USA/USA/16/0082852 DR REDDYS WHALEN R, LARION S, LYNCH T. IMPROVED RENAL AND COGNITIVE FUNCTION IN A HOSPICE PATIENT AFTER POLYPHARMACY REDUCTION. ANN LONG TERM CARE. 2014;22(10):37-40. 93.00 YR F Y 0.00000 20160901 MD COUNTRY NOT SPECIFIED US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127072681 12707268 1 PS Donepezil Hydrochloride Tablets DONEPEZIL HYDROCHLORIDE 1 Oral Y U UNKNOWN 201001 10 MG TABLET QD
127072681 12707268 2 SS FAMOTIDINE. FAMOTIDINE 1 Oral Y U UNKNOWN 75718 20 MG BID
127072681 12707268 3 SS FAMOTIDINE. FAMOTIDINE 1 Oral Y U UNKNOWN 75718 10 MG QD
127072681 12707268 4 SS MEMANTINE HYDROCHLORIDE. MEMANTINE HYDROCHLORIDE 1 Oral Y U UNKNOWN 90048 10 MG TABLET BID
127072681 12707268 5 SS MONTELUKAST MONTELUKAST SODIUM 1 Oral Y U UNKNOWN 201582 10 MG TABLET
127072681 12707268 6 SS ALPRAZOLAM. ALPRAZOLAM 1 Oral 0 .25 MG TABLET BID
127072681 12707268 7 SS fluticasone/salmeterol FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Oral 250/50 MCG INHALATION EVERY 12 HOURS 0
127072681 12707268 8 SS MIRTAZAPINE. MIRTAZAPINE 1 Oral AT BED TIME UNKNOWN 0 15 MG TABLET
127072681 12707268 9 SS MIRTAZAPINE. MIRTAZAPINE 1 Oral AT BED TIME UNKNOWN 0 7.5 MG TABLET QD
127072681 12707268 10 SS METOPROLOL. METOPROLOL 1 Oral 0 50 MG TABLET QD
127072681 12707268 11 SS ZOLPIDEM ZOLPIDEMOLPIDEM TARTRATE 1 Oral AT BED TIME 0 6.25 MG TABLET QD
127072681 12707268 12 C ACETAMINOPHEN. ACETAMINOPHEN 1 Oral 0 1000 MG TID
127072681 12707268 13 C AMLODIPINE AMLODIPINE BESYLATE 1 Oral 0 10 MG QD
127072681 12707268 14 C CLOPIDOGREL CLOPIDOGREL BISULFATE 1 Oral AT BEDTIME 0 75 MG TABLET QD
127072681 12707268 15 C LEVOTHYROXINE. LEVOTHYROXINE 1 Oral 0 125 UG TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127072681 12707268 1 Dementia
127072681 12707268 2 Gastrooesophageal reflux disease
127072681 12707268 4 Dementia
127072681 12707268 5 Asthma
127072681 12707268 6 Agitation
127072681 12707268 7 Asthma
127072681 12707268 8 Depression
127072681 12707268 9 Decreased appetite
127072681 12707268 10 Hypertension
127072681 12707268 11 Insomnia
127072681 12707268 12 Fracture pain
127072681 12707268 13 Hypertension
127072681 12707268 14 Coronary artery disease
127072681 12707268 15 Hypothyroidism

Outcome of event

Event ID CASEID OUTC COD
127072681 12707268 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127072681 12707268 Drug ineffective
127072681 12707268 Neurological symptom
127072681 12707268 Product use issue
127072681 12707268 Psychiatric symptom
127072681 12707268 Somnolence

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found